Company Profile
GlaxoSmithKline Pharmaceuticals manufactures, distributes, and trades in pharmaceuticals in India and globally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B. Its portfolio also includes Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media, Havrix for active immunization against disease caused by Hepatitis A virus, Menveo to prevent invasive meningococcal disease, Boostrix for immunization against diphtheria, tetanus and pertussis, Fluarix Tetra for the prevention of influenza disease, Varilrix for active immunization against varicella, and Shingrix for prevention of herpes zoster and post-herpetic neuralgia, as well as specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and Trelegy Ellipta for treating chronic obstructive pulmonary disease.
Additionally, it offers general medicines, including AUGMENTIN and CEFTUM, an oral antibiotic to treat bacterial infections. Its portfolio also includes CobadexCZS to treat mineral and vitamins deficiency states in adult patients, Flutivate, a skin cream for adults, children and infants, Tenovate to treat inflammatory and pruritic manifestations of steroid responsive dermatosis, CALPOL to treat mild to moderate pain, ELTROXIN for hypothyroidism, CCM to treat calcium and vitamin D deficiency, NEOSPORIN for treatment of specific bacterial skin infections, BETNOVATE for skin conditions, T-BACT for bacterial skin infections, and PHYSIOGEL for dry skin associated with redness and itch.
Formerly known as SmithKline Beecham Pharmaceuticals India Ltd., the company rebranded as GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is based in Mumbai, India.